Cargando…

Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma

PURPOSE: To investigate the prognostic factors and survival analysis of patients with hepatocellular carcinoma with distant metastasis. METHODS: The clinical data of 3,126 patients with distant metastasis of hepatocellular carcinoma from 2010 to 2015 were extracted from SEER database, and the correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Hao, Zhao, Xue, Lu, Zhaoxue, Yao, Yuanhu, Zhang, Xuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141638/
https://www.ncbi.nlm.nih.gov/pubmed/34041022
http://dx.doi.org/10.3389/fonc.2021.652768
_version_ 1783696405634744320
author Zhan, Hao
Zhao, Xue
Lu, Zhaoxue
Yao, Yuanhu
Zhang, Xuguang
author_facet Zhan, Hao
Zhao, Xue
Lu, Zhaoxue
Yao, Yuanhu
Zhang, Xuguang
author_sort Zhan, Hao
collection PubMed
description PURPOSE: To investigate the prognostic factors and survival analysis of patients with hepatocellular carcinoma with distant metastasis. METHODS: The clinical data of 3,126 patients with distant metastasis of hepatocellular carcinoma from 2010 to 2015 were extracted from SEER database, and the correlation between the location of distant metastasis of hepatocellular carcinoma and prognosis was retrospectively analyzed. Patients were grouped according to different metastatic sites. The clinical characteristics of each group were compared by chi-square test, the survival curve was drawn by Kaplan-Meier method, Log-rank test was used for univariate analysis, and Cox regression for multivariate analysis. And use propensity score matching (PSM) to reduce differences in baseline characteristics. RESULTS: Before PSM, the prognosis of patients with hepatocellular carcinoma with lung metastasis is worse than that of patients without lung metastasis. And there was no statistically significant difference with or without bone metastases.Patients with one type of organ metastasis had better prognosis than those with multiple organ metastasis. Among patients with organ metastasis, bone metastasis has a better prognosis than patients with lung metastasis. After PSM, patients with HCC with bone metastases had a worse prognosis than those without bone metastases (P<0.05). Univariate analysis showed that the degree of tumor differentiation, T stage, N stage, primary tumor and metastatic surgery, radiotherapy and chemotherapy, tumor size, single organ metastasis, the number of metastatic organs, and the combination of metastatic organs were related to the prognosis of patients with distant metastasis of hepatocellular carcinoma (P < 0.05). Multiariate analysis showed that age ≥52 years old, male, low degree of tumor differentiation, N1 stage, no primary surgery, no chemoradiotherapy, tumor size > 6cm, and multi-organ metastasis were independent influencing factors for poor prognosis in patients with metastatic hepatocellular carcinoma. CONCLUSION: The lung is the most common site of distant metastasis of hepatocellular carcinoma. Single organ metastasis has better prognosis than multiple organ metastasis. Age ≥52 years old, male, low degree of tumor differentiation, N1 stage, no primary surgery, no chemoradiotherapy, tumor size > 6cm, and multi-organ metastasis were independent influencing factors for poor overall survival and cancer-specific survival prognosis in patients with metastatic hepatocellular carcinoma.
format Online
Article
Text
id pubmed-8141638
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81416382021-05-25 Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma Zhan, Hao Zhao, Xue Lu, Zhaoxue Yao, Yuanhu Zhang, Xuguang Front Oncol Oncology PURPOSE: To investigate the prognostic factors and survival analysis of patients with hepatocellular carcinoma with distant metastasis. METHODS: The clinical data of 3,126 patients with distant metastasis of hepatocellular carcinoma from 2010 to 2015 were extracted from SEER database, and the correlation between the location of distant metastasis of hepatocellular carcinoma and prognosis was retrospectively analyzed. Patients were grouped according to different metastatic sites. The clinical characteristics of each group were compared by chi-square test, the survival curve was drawn by Kaplan-Meier method, Log-rank test was used for univariate analysis, and Cox regression for multivariate analysis. And use propensity score matching (PSM) to reduce differences in baseline characteristics. RESULTS: Before PSM, the prognosis of patients with hepatocellular carcinoma with lung metastasis is worse than that of patients without lung metastasis. And there was no statistically significant difference with or without bone metastases.Patients with one type of organ metastasis had better prognosis than those with multiple organ metastasis. Among patients with organ metastasis, bone metastasis has a better prognosis than patients with lung metastasis. After PSM, patients with HCC with bone metastases had a worse prognosis than those without bone metastases (P<0.05). Univariate analysis showed that the degree of tumor differentiation, T stage, N stage, primary tumor and metastatic surgery, radiotherapy and chemotherapy, tumor size, single organ metastasis, the number of metastatic organs, and the combination of metastatic organs were related to the prognosis of patients with distant metastasis of hepatocellular carcinoma (P < 0.05). Multiariate analysis showed that age ≥52 years old, male, low degree of tumor differentiation, N1 stage, no primary surgery, no chemoradiotherapy, tumor size > 6cm, and multi-organ metastasis were independent influencing factors for poor prognosis in patients with metastatic hepatocellular carcinoma. CONCLUSION: The lung is the most common site of distant metastasis of hepatocellular carcinoma. Single organ metastasis has better prognosis than multiple organ metastasis. Age ≥52 years old, male, low degree of tumor differentiation, N1 stage, no primary surgery, no chemoradiotherapy, tumor size > 6cm, and multi-organ metastasis were independent influencing factors for poor overall survival and cancer-specific survival prognosis in patients with metastatic hepatocellular carcinoma. Frontiers Media S.A. 2021-05-10 /pmc/articles/PMC8141638/ /pubmed/34041022 http://dx.doi.org/10.3389/fonc.2021.652768 Text en Copyright © 2021 Zhan, Zhao, Lu, Yao and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhan, Hao
Zhao, Xue
Lu, Zhaoxue
Yao, Yuanhu
Zhang, Xuguang
Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title_full Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title_fullStr Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title_full_unstemmed Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title_short Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
title_sort correlation and survival analysis of distant metastasis site and prognosis in patients with hepatocellular carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141638/
https://www.ncbi.nlm.nih.gov/pubmed/34041022
http://dx.doi.org/10.3389/fonc.2021.652768
work_keys_str_mv AT zhanhao correlationandsurvivalanalysisofdistantmetastasissiteandprognosisinpatientswithhepatocellularcarcinoma
AT zhaoxue correlationandsurvivalanalysisofdistantmetastasissiteandprognosisinpatientswithhepatocellularcarcinoma
AT luzhaoxue correlationandsurvivalanalysisofdistantmetastasissiteandprognosisinpatientswithhepatocellularcarcinoma
AT yaoyuanhu correlationandsurvivalanalysisofdistantmetastasissiteandprognosisinpatientswithhepatocellularcarcinoma
AT zhangxuguang correlationandsurvivalanalysisofdistantmetastasissiteandprognosisinpatientswithhepatocellularcarcinoma